• Home
  • NEW DAY MEDICINE
  • 7(45)2022
  • 69 -7 (45) 2022 — Kodirova Sh.R. — AGE-RELATED CATARACT: PREVENTION AND A MODERN VIEW ON CONSERVATIVE APPROACHES TO TREATMENT

69 -7 (45) 2022 — Kodirova Sh.R. — AGE-RELATED CATARACT: PREVENTION AND A MODERN VIEW ON CONSERVATIVE APPROACHES TO TREATMENT

AGE-RELATED CATARACT: PREVENTION AND A MODERN VIEW ON CONSERVATIVE APPROACHES TO TREATMENT

Kodirova Sh.R. Central multidisciplinary polyclinic of the Uchtepa district. Tashkent city. Uzbekistan

Resume

Purpose: prevention and modern view on conservative approaches to the treatment of senile cataracts. Risk factors for cataract development: Although up to half of congenital cataracts are due to genetic factors, their influence on the development of primary cataracts in adulthood is still poorly understood. More specific risk factors for cataract development include ionizing radiation, a number of drugs (corticosteroids, phenothiazines, miotics, busulfan; possibly amiodarone and statins), dietary and environmental factors.

Cataract as a nosological unit. Congenital and traumatic cataracts, which make up a small percentage in the epidemiological situation: 90% of patients have age-related (primary) cataracts. Cataract Treatment: The only effective treatment for cataracts at the moment is cataract surgery. In combination with combined preparations with a composition that is aimed at slowing the development of cataracts in patients who are not ready for surgical treatment. Conclusion: Thus, the importance of developing non-surgical approaches to the prevention and treatment of cataracts, taking into account the pathogenesis of this disease, becomes obvious.

Key words: Age-related cataract, prevention, treatment, oftan-katahrom

First page

367

Last page

373

For citation: Kodirova Sh.R. AGE-RELATED CATARACT: PREVENTION AND A MODERN VIEW ON CONSERVATIVE APPROACHES TO TREATMENT //New Day in Medicine 7(45)2022 367-373 https://clck.ru/sNjHZ

LIST OF REFERENCES:

  1. Flaxman S.R., Bourne R.R.A., Resnikoff S. et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. // Lancet Glob Health. 2017;5(12): e1221-e1234. DOI: 10.1016/S2214-109X (17) 30393-5.
  2. Орлова А.М., Трубилин В.Н., Жуденков К.В. Анализ прогрессирования катаракты в России с учетом данных естественной смертности населения. Практическая медицина. 2016;94(2):70-73. [Orlova A.M., Trubilin V.N., Zhudenkov K.V. Analysis of cataract progression in Russia based on natural mortality data. Prakticheskaya meditsina. 2016;94(2):70-73 (in Russ.)].
  3. Liao J., Su X., Chen P. et al. Meta-analysis of genome-wide association studies in multiethnic Asians identifies two loci for age-related nuclear cataract. // Hum Mol Genet. 2014;23(22):6119–6128. DOI: 10.1093/hmg/ddu315.
  4. Zhu R.R., Shi J., Yang M., Guan H.J. Prevalences and causes of vision impairment in elderly Chinese: a socioeconomic perspective of a comparative report nested in Jiangsu Eye Study. // Int J Ophthalmol. 2016;9(7):1051–1056. DOI: 10.18240/ijo.2016.07.19.
  5. Delcourt C., Cristol J.P., Tessier F. et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Pathologies Oculaires Liees a l’Age. // Am J Epidemiol. 2000;151(5):497-504. DOI: 10.1093/oxfordjournals.aje.a010235.
  6. Klein B.E., Klein R., Wang Q., Moss S.E. Older-onset diabetes and lens opacities. // The Beaver Dam Eye Study. Ophthalmic Epidemiol. 1995;2(1):49-55.
  7. Li J., Tripathi R.C., Tripathi B.J. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127-141. DOI: 10.2165/00002018-200831020-00003.
  8. Chang D.F., Osher R.H., Wang L., Koch D.D. Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax). // Ophthalmology. 2007;114(5):957-964. DOI: 9.1016/j.ophtha.2007.01.011.
  9. Wride M.A. Lens fibre cell differentiation and organelle loss: many paths lead to clarity. // Philos Trans R Soc Lond B Biol Sci. 2011; 366(1568):1219-1233. DOI: 10.1098/rstb.2010.0324.
  10. Королева И.А., Егоров А.Е. Метаболизм хрусталика: особенности и пути коррекции. // РМЖ. Клиническая офтальмология. 2015; 15(4):191-195. [Koroleva I.A., Egorov A.E. Lens metabolism: features and ways of correction. RMJ. Russian Journal of Clinical Ophthalmology. 2015;15(4):191-195 (in Russ.)].
  11. Ramirez D.A., Brodie F.L., Rose-Nussbaumer J., Ramanathan S. Anxiety in patients undergoing cataract surgery: a pre- and postoperative comparison. // Clin Ophthalmol. 2017;11:1979-1986. DOI: 10.2147/OPTH.S146135.
  12. Zhao L., Chen X.J., Zhu J. et al. Lanosterol reverses protein aggregation in cataracts. Nature. 2015;523(7562):607–611. DOI: 10.1038/nature14650.
  13. Zhao L., Chen X.J., Zhu J. et al. Corrigendum: Lanosterol reverses protein aggregation in cataracts. Nature. 2015;526(7574):595. DOI: 10.1038/nature15253.
  14. Mayer H., König H. Objective evaluation of cataract development under treatment with cytochrome C, sodium succinate, adenosine, nicotinamide and sorbitol. Fortschr Ophthalmol. 1987;84(3):261–264.
  15. Полунин Г.С. Эффективность медикаментозного лечения различных видов катаракт. // Consilium Medicum. 2001; 12(1):9-11. [Polunin G.S. The effectiveness of drug treatment of various types of cataracts. Consilium Medicum. 2001;12(1):9-11 (in Russ.)].
  16. Гусаревич О.Г., Фурсова А.Ж., Колосова Н.Г. Изучение влияния Офтан Катахрома на развитие макулярной дегенерации сетчатки. // РМЖ. Клиническая офтальмология. 2003 (4):186-189. [Gusarevich O.G., Fursova A.Zh., Kolosova N.G. Study of the influence of Oftan Сatachrom on the development of macular degeneration of the retina. RMJ. Russian Journal of Clinical Ophthalmology. 2003 (4):186-189 (in Russ.)].
  17. Егорова Е.В. Ультразвуковая терапия и инстилляции противокатарактальных препаратов в комплексном лечении больных с возрастной катарактой. // Вестник СамГУ. Естественно-научная серия. 2006; 46(2):223–239. [Egorova E.V. Ultrasound therapy and instillation of anti-cataract drugs in the complex treatment of patients with age-related cataract. Vestnik SamGU. Estestvenno-nauchnaya seriya. 2006; 46(2):223-239 (in Russ.)].
  18. Егорова Е.В., Малов В.М., Ерошевская Е.Б. Эффективность инстилляций противокатарактального препарата Офтан® Катахром и ультразвуковой терапии в профилактике прогрессирования возрастной катаракты. // РМЖ. Клиническая офтальмология. 2007(3):123-124. [Egorova E.V., Malov V.M., Eroshevskaya E.B. The effectiveness of instillations of the cataract drug Oftan Catahrom and ultrasound therapy in the prevention of progression of age-related cataract. RMJ. Russian Journal of Clinical Ophthalmology. 2007 (3):123-124 (in Russ.)].
  19. Лумпова Т.Н. Применение глазных капель Офтан Катахром для лечения осложненной катаракты при глаукоме. // РМЖ. Клиническая офтальмология. 2007(4):167-168. [Lumpova T.N.]. The use of Oftan Katahrom eye drops for the treatment of complicated cataracts for glaucoma. RMJ. Russian Journal of Clinical Ophthalmology. 2007 (4):167-168 (in Russ.)].

file

download